BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study
Main Authors: | Zhen, David B., Rabe, Kari G., Gallinger, Steven, Syngal, Sapna, Schwartz, Ann G., Goggins, Michael G., Hruban, Ralph H., Cote, Michele L., McWilliams, Robert R., Roberts, Nicholas J., Cannon-Albright, Lisa A., Li, Donghui, Moyes, Kelsey, Wenstrup, Richard J., Hartman, Anne-Renee, Seminara, Daniela, Klein, Alison P., Petersen, Gloria M. |
---|---|
Format: | Online |
Language: | English |
Published: |
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439391/ |
Similar Items
-
Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2
by: Hartford, Suzanne A., et al.
Published: (2016) -
Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
by: Wojcik, P., et al.
Published: (2016) -
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
by: Blanco, Ana, et al.
Published: (2013) -
Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer
by: Pern, Franziska, et al.
Published: (2012) -
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada
by: Hartley, Taila, et al.
Published: (2014)